In a regulatory filing made during market hours today, Natco Pharma announced that it has received an establishment ...

Q1FY26 revenues at ?12.7 billion, YoY growth of 142% and flat QoQ growth. This includes revenues from the acquired NRT business.

A Form 483 is issued by the US health regulator when inspectors identify conditions that may violate the Food, Drug, and ...

A Form 483 is issued at the conclusion of an inspection when USFDA investigators observe conditions that may be in violation ...